Arcutis grants 62,500 RSUs to six new hires under 2022 inducement plan
ARQT•Arcutis Biotherapeutics granted 62,500 restricted stock units to six new employees, with awards dated Oct. 1, 2026, and vesting over four years.
1. Award terms
Arcutis Biotherapeutics granted 62,500 restricted stock units to six newly hired employees under its 2022 Inducement Plan. The awards carry a grant date of Oct. 1, 2026, and vest 25% on each annual anniversary, contingent on continued employment.
